InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Campbell Chad Thomas, Chief Executive Officer. Director active across 1 companies, notably Angiodynamics INC. Aggregated, 10 reports have been logged. The latest transaction was disclosed on 5 October 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations10 total
€153,76710,748 shares@ €14.30660.035% mcap88.6% of flow
Common Stock
SEC:0001567619-21-017999·
€153,76710,748 shares@ €14.30660.035% mcap44.3% of flow
Common Stock
SEC:0001567619-21-017999:0·
08,210 shares0
Common Stock
SEC:0001567619-21-016025·
08,210 shares0
Common Stock
SEC:0001567619-21-016025:0·
02,395 shares0
Common Stock
SEC:0001567619-21-015950·
02,395 shares0
Common Stock
SEC:0001567619-21-015950:0·
€7,029318 shares@ €22.10410.0016% mcap4.1% of flow
Common Stock
SEC:0001567619-21-014063·
€7,029318 shares@ €22.10410.0016% mcap2.0% of flow
Common Stock
SEC:0001567619-21-014063:0·
€12,753571 shares@ €22.33520.0029% mcap7.3% of flow
Common Stock
SEC:0001567619-21-013920·
€12,753571 shares@ €22.33520.0029% mcap3.7% of flow
Common Stock
SEC:0001567619-21-013920:0·
10 of 10 declarations
About Campbell Chad Thomas
Chad Thomas Campbell is the Senior Vice President and General Manager of Vascular Access at AngioDynamics Inc. He is responsible for the strategic and operational leadership of the division, contributing to the innovation and expansion of the company's products in the vascular access field. His expertise in management and product development is essential for achieving the company's growth objectives.
